Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Captopril 50mg tablets
0205051F0AAAFAF
|
Captopril | Captopril | Cardiovascular System | 6,223 |
|
Captopril 25mg tablets
0205051F0AAAEAE
|
Captopril | Captopril | Cardiovascular System | 5,470 |
|
Captopril 12.5mg tablets
0205051F0AAADAD
|
Captopril | Captopril | Cardiovascular System | 1,897 |
|
Captopril 25mg/5ml oral solution sugar free
0205051F0AADZDZ
|
Captopril | Captopril | Cardiovascular System | 1,592 |
|
Captopril 5mg/5ml oral solution sugar free
0205051F0AAEAEA
|
Captopril | Captopril | Cardiovascular System | 805 |
|
Captopril 25mg/5ml oral liquid
0205051F0AABWBW
|
Captopril | Captopril | Cardiovascular System | 26 |
|
Noyada 25mg/5ml oral solution
0205051F0BIAADZ
|
Noyada | Captopril | Cardiovascular System | 15 |
|
Captopril 3mg/5ml oral liquid
0205051F0AACDCD
|
Captopril | Captopril | Cardiovascular System | 5 |
|
Noyada 5mg/5ml oral solution
0205051F0BIABEA
|
Noyada | Captopril | Cardiovascular System | 3 |
|
Captopril 5mg/5ml oral liquid
0205051F0AABNBN
|
Captopril | Captopril | Cardiovascular System | 2 |
|
Captopril 6.25mg/5ml oral liquid
0205051F0AABXBX
|
Captopril | Captopril | Cardiovascular System | 2 |
|
Captopril 12.5mg/5ml oral liquid
0205051F0AABTBT
|
Captopril | Captopril | Cardiovascular System | 1 |
|
Captopril 50mg capsules
0205051F0AADUDU
|
Captopril | Captopril | Cardiovascular System | 1 |
|
Acepril 12.5mg tablets
0205051F0BBAAAD
|
Acepril | Captopril | Cardiovascular System | No data available |
|
Acepril 25mg tablets
0205051F0BBABAE
|
Acepril | Captopril | Cardiovascular System | No data available |
|
Acepril 50mg tablets
0205051F0BBACAF
|
Acepril | Captopril | Cardiovascular System | No data available |
|
Capoten 12.5mg tablets
0205051F0BCADAD
|
Capoten | Captopril | Cardiovascular System | No data available |
|
Capoten 25mg tablets
0205051F0BCABAE
|
Capoten | Captopril | Cardiovascular System | No data available |
|
Capoten 50mg tablets
0205051F0BCACAF
|
Capoten | Captopril | Cardiovascular System | No data available |
|
Capoten 5mg/ml oral solution
0205051F0BCAFCT
|
Capoten | Captopril | Cardiovascular System | No data available |
|
Captomex 12.5mg tablets
0205051F0BHAAAD
|
Captomex | Captopril | Cardiovascular System | No data available |
|
Captomex 25mg tablets
0205051F0BHACAE
|
Captomex | Captopril | Cardiovascular System | No data available |
|
Captomex 50mg tablets
0205051F0BHABAF
|
Captomex | Captopril | Cardiovascular System | No data available |
|
Captopril 1.25mg/5ml oral liquid
0205051F0AABVBV
|
Captopril | Captopril | Cardiovascular System | No data available |
|
Captopril 1.5mg capsules
0205051F0AABKBK
|
Captopril | Captopril | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.